Your browser doesn't support javascript.
loading
Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases.
Otero-Ortega, Laura; Fernández-Fournier, Mireya; Irizar, Haritz; Otaegui, David; Díez-Tejedor, Exuperio.
Affiliation
  • Otero-Ortega L; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain.
  • Fernández-Fournier M; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain.
  • Irizar H; Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Otaegui D; Multiple Sclerosis Group, Neurosciences Area, Biodonostia Health Research Institute, San Sebastian, Spain.
  • Díez-Tejedor E; Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain.
Front Immunol ; 14: 1348986, 2023.
Article in En | MEDLINE | ID: mdl-38173727
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Spain